Skip to main content
. Author manuscript; available in PMC: 2010 Sep 3.
Published in final edited form as: Eur J Cancer. 2007 Jul 5;43(12):1849–1855. doi: 10.1016/j.ejca.2007.05.016

Table 1.

HPV-status post-treatment related to time until recurrence was noted

Time between treatment and
recurrence (for cases)
Cases HPVpos Controls HPVpos OR of HPVpos
2–16.3 Years (whole population) 45/189 (24%) 44/378 (12%) 2.5 (1.6–3.8)
2–3.6 Years 21/63 (33%) 14/126 (11%) 4.9 (2.2–11.0)
3.6–6.7 Years 14/63 (22%) 12/126 (10%) 2.4 (1.1–5.3)
>6.7 Years 10/63 (16%) 18/126 (14%) 1.1 (0.5–2.5)
Test for trend p < 0.05

HPV-positivity was defined as presence of HPV-DNA in any smear. Odds ratios (ORs) with 95% confidence intervals.